Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXCC6F
|
||||
| Drug Name |
(7,8-dimethoxy-10,11-dihydro-5H-2,4,5,11-tetraaza-dibenzo[a,d]cyclohepten-1-yl)-(3-methoxy-benzyl)-amine
|
||||
| Synonyms |
CHEMBL216039
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C21H23N5O3
|
||||
| Canonical SMILES |
COc1cccc(CNc2ncnc3Nc4cc(OC)c(OC)cc4CNc23)c1
|
||||
| InChI |
InChI=1S/C21H23N5O3/c1-27-15-6-4-5-13(7-15)10-23-20-19-21(25-12-24-20)26-16-9-18(29-3)17(28-2)8-14(16)11-22-19/h4-9,12,22H,10-11H2,1-3H3,(H2,23,24,25,26)
|
||||
| InChIKey |
RDWCIHJLPRFOAX-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Epidermal growth factor receptor III | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.